Bilgi Ana Sayfa İnsan Sağlığı Bilgi All Görüş Belgeler Popüler Bilim Mülakatlar Süzgeç Therapeutic areasCOVID-19Sindirim sağlığı Apply Ana Sayfa İnsan Sağlığı Bilgi RBDCOV: The project’s origins and future endeavours Ana Sayfa İnsan Sağlığı Bilgi Reactogenicity of third and fourth booster doses of HIPRA PHH-1V, a bivalent recombinant protein vaccine against SARS-CoV-2 Ana Sayfa İnsan Sağlığı Bilgi Humoral immune response against SARS-CoV-2 variants of PHH-1V booster vaccine in subjects previously vaccinated with a mRNA vaccine Ana Sayfa İnsan Sağlığı Bilgi One-year humoral response of PHH-1V booster vaccine in subjects previously vaccinated against COVID-19 with a mRNA vaccine Ana Sayfa İnsan Sağlığı Bilgi Dr. Àlex Soriano (Hospital Clínic de Barcelona): "Public-private collaboration is essential to achieve significant scientific advances" Ana Sayfa İnsan Sağlığı Bilgi Update on BIMERVAX® immunogenicity amplitude. Insights on humoral response against XBB.1.5 from an extension study Ana Sayfa İnsan Sağlığı Bilgi Alicante-Winter Immunology Symposium in Health (A-Wish) and the Boulle-SEI awards Ana Sayfa İnsan Sağlığı Bilgi The PHH-1V HIPRA vaccine: a new tool in the vaccination strategy against COVID-19 Ana Sayfa İnsan Sağlığı Bilgi How do COVID-19 vaccines work?
